Laser and light source treatments target many of the most common skin conditions that dermatologists encounter. The recent expansion in laser dermatology is both promising and exciting as the treatments available to derms and their patients continue to grow. New technologies are taking laser and light source treatments in new directions of skin structure imaging, epidermal harvesting, tissue rejuvenation, and new types of photodynamic therapies.
This month we’re looking at some allergy guideline recommendations, discuss whether or not ‘natural’ soap is milder and novel immunomodulaters.
Alexander Miller, MD, a dermatologist in Yorba Linda, Calif., has a simple message for colleagues grappling with the new ICD-10 codes: Don't panic!
A panel of veteran dermatologists tackled the topic of difficult patients at the 2016 CalDerm Symposium and offered some tips for successfully dealing with these patients.
After a sudden urge to tidy up his office, Dr. Ronald G. Wheeland developed another urge to figure out what to do with his old dermatology books and journals.
It is important to note that where there are two or more recognized methods of diagnosing or treating the same condition, a physician does not fall below the standard of care by using any of the acceptable methods even if one method turns out to be less effective than another method.
Dr. Mark Lebwohl talks about the FDA’s approval of the anti-interleukin-17 receptor monoclonal antibody brodalumab (Siliq, Valeant Pharmaceuticals) for treatment of adults with moderate-to-severe plaque psoriasis.
There has been recent concern about the safety of parabens as they are the most frequently used preservative in skin care products today
Providing safe products that consumers can use with confidence requires preservatives. However, the concept of preservation is not unique to skin care products.
Many skin care products are now advertising the “paraben-free” claim, however the parabens must be replaced with another preservative.
Safety concerns over parabens arose because they mimic estrogen by binding to estrogen receptors.
No one is really sure what constitutes a natural skin care product, since all ingredients are natural to the earth!
In skin of color, psoriasis can be tough to spot, and it carries a broader differential diagnosis. Darker-skinned patients may not know that they can develop psoriasis, or the importance of seeking treatment early.
Available resources of the Center include human pathology specimens and database info on living consented patients. Techniques such as tissue imaging, gene expression analysis, T-cell receptor, sequencing studies, and CyTOF analyses are available. Visiting Scholar grants funds allow researchers to learn how to work with human tissue and how to use new techniques.
Being able to predict which patients will respond to which treatments will help dermatologists in treating psoriasis, preventing progression to psoriatic arthritis and reducing comorbidities.
PDT is underutilized as field treatment for AKs. An expert pushes for two to three hours' incubation time in her clinic and suggests efficacy-elevating pretreatment of lesions.
A new research center makes a database of five million human pathology specimens and 22,000 living consented patients, all searchable by diagnoses, as well as cutting edge human analytic techniques available to anyone interested in carrying out translational skin disease research on human cells and tissues.
Taking the sting and stress out of dermatologic procedures requires low-tech distraction techniques and, often in the case of children, amusing apps.
Knowing the genetic basis of monogenic skin diseases may one day help dermatologists treat non-monogenic skin diseases as well.
CMS' meaningful use program for electronic health records (EHRs) has morphed into the Advancing Care Information (ACI) initiative, which loosens restrictions for earning EHR bonuses.
Promising new treatments recently approved or under development for atopic dermatitis include crisaborole, JAK inhibitors and dupilumab, an expert said.
Important recent publications from mainstream medical journals highlight the following: Automobile side windows do not block UV radiation well; An adjuvant herpes zoster vaccine works as well in patients over 70 years old as it did in the 50-plus age group; The American Academy of Ophthalmology recommends hydroxychloroquine and chloroquine dosing based on actual, not ideal, weight.
A recent pediatric allergy study spells out how to safely introduce peanuts to high-risk (and other) children. Another study suggests that melatonin may have immunomodulatory effects in AD.
The American Academy of Dermatology kicks off March 3. Follow here for updates on advancements in clinical dermatology.
Researchers have developed a 3D printer that applies skin cells onto burn wounds. Bio-printed cells enhanced wound healing by three to four weeks compared with untreated or matrix-treated wounds. Researchers are compiling animal data to submit an IND application for a clinical trial.
Why are drugs so expensive? It’s complicated. Who is profiting? Not just "Big Pharma". Is there a solution to this problem? Only if everyone is willing to pay their fair share.
Quality measurement, coverage trends are not new. Opportunity for specialty to develop its own valid data gathering methods. Dermatologists can seek guidance from specialties that have had success
The March Table of the Month discusses various dressing options and review times for certain wound types.
Much has been written and discussed over the last decade about accountability, particularly as it applies to the issue of liability for medical decision making in the care and treatment of healthcare plan enrollees and beneficiaries.
For answers, Dermatology Times and Cosmetic Surgery Times developed an online survey for readers. The activity presented images from 6 patients who were photographed on the day of their injection and 30 days after treatment with either Xeomin® (incobotulinumtoxinA, Merz Pharmaceuticals) or Botox® (onabotulinumtoxinA, Allergan).
